BSE Live
Jan 23, 16:01Prev. Close
201.30
Open Price
203.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 23, 15:53Prev. Close
207.16
Open Price
204.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
207.16 (2141)
| Key Financial Ratios of Viyash Scientific (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 14.44 | -44.28 | -24.01 | 0.67 | 7.26 | |
| Diluted EPS (Rs.) | 12.22 | -44.28 | -24.01 | 0.67 | 7.26 | |
| Cash EPS (Rs.) | 21.73 | -34.12 | -11.84 | 10.54 | 15.59 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 51.48 | 18.79 | 46.69 | 59.38 | 59.13 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 51.48 | 18.79 | 46.69 | 59.38 | 59.13 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 1.50 | |
| Revenue from Operations/Share (Rs.) | 126.04 | 127.51 | 133.98 | 155.78 | 130.91 | |
| PBDIT/Share (Rs.) | 18.89 | 0.32 | -1.72 | 21.93 | 27.49 | |
| PBIT/Share (Rs.) | 10.71 | -8.35 | -13.13 | 12.08 | 19.40 | |
| PBT/Share (Rs.) | -11.36 | -42.60 | -26.80 | -1.17 | 10.46 | |
| Net Profit/Share (Rs.) | 13.55 | -42.79 | -23.25 | 0.69 | 7.50 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 14.98 | 0.25 | -1.28 | 14.07 | 21.00 | |
| PBIT Margin (%) | 8.49 | -6.54 | -9.79 | 7.75 | 14.82 | |
| PBT Margin (%) | -9.01 | -33.41 | -20.00 | -0.75 | 7.99 | |
| Net Profit Margin (%) | 10.75 | -33.55 | -17.35 | 0.44 | 5.73 | |
| Return on Networth / Equity (%) | 26.32 | -227.68 | -49.79 | 1.15 | 12.68 | |
| Return on Capital Employed (%) | 18.67 | -76.94 | -24.39 | 0.72 | 6.93 | |
| Return on Assets (%) | 6.35 | -20.43 | -10.09 | 0.29 | 3.78 | |
| Total Debt/Equity (X) | 2.09 | 6.61 | 2.26 | 1.27 | 1.25 | |
| Asset Turnover Ratio (%) | 59.07 | 60.88 | 58.14 | 66.96 | 66.08 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.56 | 0.58 | 0.69 | 0.73 | 0.86 | |
| Quick Ratio (X) | 0.41 | 0.33 | 0.43 | 0.51 | 0.53 | |
| Inventory Turnover Ratio (X) | 5.74 | 3.37 | 3.80 | 5.27 | 4.52 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 20.65 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 9.93 | |
| Earnings Retention Ratio (%) | 100.00 | 0.00 | 0.00 | 100.00 | 79.35 | |
| Cash Earnings Retention Ratio (%) | 100.00 | 0.00 | 0.00 | 100.00 | 90.07 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 1,859.57 | 821.04 | 521.00 | 290.87 | 324.81 | |
| EV/Net Operating Revenue (X) | 4.84 | 2.41 | 1.66 | 0.87 | 1.17 | |
| EV/EBITDA (X) | 32.30 | 960.28 | -129.51 | 6.22 | 5.56 | |
| MarketCap/Net Operating Revenue (X) | 4.06 | 1.49 | 0.97 | 0.44 | 0.63 | |
| Retention Ratios (%) | 100.00 | 0.00 | 0.00 | 100.00 | 79.34 | |
| Price/BV (X) | 9.94 | 10.11 | 2.78 | 1.15 | 1.38 | |
| Price/Net Operating Revenue | 4.06 | 1.49 | 0.97 | 0.44 | 0.63 | |
| Earnings Yield | 0.03 | -0.23 | -0.18 | 0.01 | 0.09 |
02.12.2025
Sequent Scienti Standalone September 2025 Net Sales at Rs 34.03 crore, down 18.96% Y-o-Y
22.08.2025
Sequent Scienti Standalone June 2025 Net Sales at Rs 41.07 crore, down 28.78% Y-o-Y
21.05.2025
Sequent Scienti Standalone March 2025 Net Sales at Rs 42.33 crore, up 15.12% Y-o-Y
24.02.2025
Sequent Scienti Consolidated December 2024 Net Sales at Rs 390.81 crore, up 18.66% Y-o-Y